41/133US=10 / Urologia
Kirby RS. Managing the complications of advanced prostate cancer. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 365-74. ISBN 978-0415-458933-1.

CANCER DE PROSTATA; COMPLICACOES; TRATO URINARIO INFERIOR; UROPATIA OBSTRUTIVA; COMPRESSAO DA MEDULA ESPINHAL


42/133US=110 / Câncer
Sideras K, Loprinzi CL, Foote RL. Oral complications. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 609-23. ISBN 978-0-443-06695-5.

CANCER; QUIMIOTERAPIA; LESAO DA MUCOSA; QUIMIOTERAPIA MIELOABLATIVA; RADIOTERAPIA; MUCOSITE; XEROSTOMIA; CARIE DENTARIA; NECROSE OSSEA; NECROSE DE TECIDOS MOLES; TRISMO


43/133US=110 / Câncer
Robinson-Bostom L, Kawaoka J, Rupani R, McDonald CJ. Alopecia and cutaneous complications. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 625-40. ISBN 978-0-443-06695-5.

CANCER; ALOPECIA; COMPLICACOES CUTANEAS; CELULITE; FLEBITE; DISESTESIA PALMAR-PLANTAR; ERITRODISESTESIA; ERITEMA ACRAL; HIPERPIGMENTACAO; ALTERACOES NAS UNHAS; DERMATITE; HIDRADENITE ECRINA NEUTROFILICA; METAPLASIA SIRINGOESCAMOSA; MODIFICADORES DE RESPOSTA BIOLOGICA; REACAO CUTANEA; INTERLEUKIN-2; INIBIDORES PROTEOSSOMICOS


44/133US=110 / Câncer
Gilbert MR. Neurologic complications. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 945-67. ISBN 978-0-443-06695-5.

CANCER; QUIMIOTERAPIA; COMPLICACOES NEUROLOGICAS; AGENTES QUIMIOTERAPICOS; MODIFICADORES DE RESPOSTA BIOLOGICA; NEUROTOXICIDADE POR RADIACAO


45/133US=110 / Câncer
Machtay M. Pulmonary complications of anticancer treatment. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 969-81. ISBN 978-0-443-06695-5.

CANCER. TRATAMENTO; COMPLICACOES PULMONARES; TOXICIDADE PULMONAR; RADIOTERAPIA TORACICA; TERAPIA SISTEMICA


46/133US=110 / Câncer
O´Connor T, Trump DL. Reproductive complications. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 999-1011. ISBN 978-0-443-06695-5.

CANCER. TRATAMENTO; COMPLICACOES REPRODUTIVAS; FISIOLOGIA REPRODUTIVA; FUNCAO REPRODUTIVA; GRAVIDEZ; QUIMIOTERAPIA; RADIOTERAPIA


47/133US=110 / Câncer
Chadha MK, Trump DL. Endocrine complications. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 1013-21. ISBN 978-0-443-06695-5.

CANCER. TRATAMENTO; COMPLICACOES ENDOCRINAS; TRATAMENTO CIRURGICO; RADIOTERAPIA; TERAPIA SISTEMICA; AGENTES BIOLOGICOS; DISFUNCAO ENDOCRINA


48/133US=11-B / Quimioterapia
Picus J, Martin MG. Gastrointestinal complications of chemotherapy. In: Perry MC. The chemotherapy source book. 4th ed. Philadelphia: Wolters Kluwer, 2008. p. 197-208. ISBN 978-0-7817-7328-7.

QUIMIOTERAPIA; COMPLICACOES GASTROINTESTINAIS; CONSTIPACAO; TIFLITE; PERFURACAO INTESTINAL; DIARREIA; NAUSEA; VOMITO; MUCOSITE


49/133US=11-B / Quimioterapia
Klein CE. Gonadal complications and teratogenicity of cancer therapy. In: Perry MC. The chemotherapy source book. 4th ed. Philadelphia: Wolters Kluwer, 2008. p. 283-96. ISBN 978-0-7817-7328-7.

QUIMIOTERAPIA; CANCER. TERAPIA; COMPLICACOES GONADAIS; TERATOGENICIDADE; EIXO HIPOTALAMO-HIPOFISE-GONADAL


50/133US=9 / Pediatria
Walsh TJ, Roilides E, Groll AH, Gonzales C, Pizzo PA. Infectious complications in pediatric cancer patients. In: Pizzo PA, Poplack DG. Principles and practice of pediatric oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins, 2006. p. 1269-329. ISBN 978-0-7817-5492-7.

ONCOLOGIA PEDIATRICA; CANCER INFANTIL; CRIANCA; INFECCAO; COMPLICACOES INFECCIOSAS; IMUNIDADE INATA; IMUNIDADE ADAPTATIVA; FEBRE; PACIENTES NEUTROPENICOS FEBRIS; TRATAMENTO ANTIBACTERIANO; AGENTES ANTIFUNGICOS; AGENTES ANTIVIRAIS; AGENTES ANTI-PNEUMOCISTOS; ANTIBIOTICOS PROFILATICOS; IMUNIZACAO; TRANSFUSAO DE GRANULOCITOS; CITOCINAS RECOMBINANTES


51/133US=15 / Gastro
Terhune K, Merchant NB, Parikh AA. Complications of pancreaticoduodenectomy. In: Lowy AM, Leach SD, Philip PA. Pancreatic cancer. New York: Springer, 2008. p. 365-84. ISBN 978-0-387-69250-0.

COMPLICACOES DO PANCREATODUODENECTOMIA; VAZAMENTO DE PANCREAS E FISTULA; PANCREATICOGASTROSTOMY X PANCREATICOJEJUNOSTOMIA


52/133US=18 / Gastro
Mayer JM, Tuncyurek P. Pancreatic trauma: diagnosis, treatment, complications, and late outcome. In: Beger HG, Matsuno S, Cameron JL. Diseases of the pancreas: current surgical therapy. New York: Springer, 2008. p. 905-10. ISBN 978-3-540-28655-4.

TRAUMA PANCREATICO; COLANGIOPANCREATOGRAFIA; LESAO PANCREATICA


53/133US=25 / Urologia
Sakr W. Defining the problem: from subclinical disease to clinically insignificant prostate cancer. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 1-11. (Currrent Clinical Urology) ISBN 978-1-58829-790-7.

CANCER DE PROSTATA; SUBCLINICA PROSTATA


54/133US=25 / Urologia
Stamey TA, Nolley R, Torti D. What every patient should know about prostate cancer before he submits to biopsy of his prostate. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 13-27. (Currrent Clinical Urology) ISBN 978-1-58829-790-7.

CANCER DE PROSTATA; BIOPSIA DA PROSTATA


55/133US=25 / Urologia
Nielsen ME, Partin AW. The role of complexed prostate-specific antigen in prostate cancer screening. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 29-41. (Currrent Clinical Urology) ISBN 978-1-58829-790-7.

PAPEL DO COMPLEXADO ANTIGENO PROSTATICO; RASTREAMENTO DO CANCER DE PROSTATA; ISOFORMAS DE PSA; COMPLEXADO POR CENTO PSA PSA LIVRE


56/133US=25 / Urologia
Canto EI, Slawin KM. Newly recognized forms of prostate-specific antigen and emerging molecular markers. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 43-59. (Currrent Clinical Urology) ISBN 978-1-58829-790-7.

ANTIGENO PROSTATICO ESPECIFICO; EMERGENTES MARCADORES MOLECULARES; ANTIGENO ESPECIFICO DA PROSTATA (PSA); FORMAS MOLECULARES DE PSA LIVRE; RASTREIO DO CANCER DA PROSTATA; MALDI-TOF; SELDI-TOF


57/133US=25 / Urologia
Carter HB. The role of prostate-specific antigen velocity in the diagnosis and management of prostate cancer. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 61-70. (Currrent Clinical Urology) ISBN 978-1-58829-790-7.

PROSTATICO ESPECIFICO; TRATAMENTO DE CANCER DE PROSTATA; BLINDAGEM; VELOCIDADE DO PSA; PSA TEMPO DE DUPLICACAO; PSA CINETICA


58/133US=25 / Urologia
Brand TC, Thompson IM. Prostate cancer screening: navigating the controversy. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 71-82. (Currrent Clinical Urology) ISBN 978-1-58829-790-7.

RASTREIO DO CANCER DA PROSTATA; CANCER DE PROSTATA; ANTIGENIO ESPECIFICO DA PROSTATA; PREVENCAO


59/133US=25 / Urologia
Karakiewicz PI, Kattan MW. Prostate cancer nomograms and how they measure up to neural networks. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 83-96. (Currrent Clinical Urology) ISBN 978-1-58829-790-7.

NOMOGRAMAS DE CANCER DE PROSTATA; NOMOGRAMAS; MODELOS DE PREVISAO; REDES NEURAIS; BLINDAGEM


60/133US=25 / Urologia
Nieder AM, Soloway MS. Preparation for prostate biopsy. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 97-104. (Currrent Clinical Urology) ISBN 978-1-58829-790-7.

PREPARACAO PARA A BIOPSIA DA PROSTATA; BIOPSIA DA PROSTATA; ANTIBIOTICOS; ENEMA; PREPARACAO DO PACIENTE


Primeira | Anterior | Próxima | Última